Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages
Crossref DOI link: https://doi.org/10.1007/s00210-015-1124-3
Published Online: 2015-05-19
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bułdak, Łukasz
Łabuzek, Krzysztof
Bułdak, Rafał Jakub
Machnik, Grzegorz
Bołdys, Aleksandra
Okopień, Bogusław
License valid from 2015-05-19